COVID-19 Study

This is a 6-Month Study in Omaha, Nebraska
Book An Appointment

This clinical trial is designed to evaluate an investigational vaccine that targets a newer Omicron variant. The study will include adults ages 50 to 64 who are generally healthy and have no underlying conditions that increase their risk for severe COVID-19.

The goals of the study are to:

  • See how well the updated vaccine prevents COVID-19 compared with a placebo

  • Assess the vaccine’s safety, side effects, and immune response

  • Understand whether the immune response after vaccination is linked to the chance of developing symptoms

  • Evaluate whether the vaccine helps prevent COVID-19 complications

How To Qualify For This Study:

Commonly Asked Questions About This Study

Why should I participate in this study?

People choose to participate in clinical trials for a variety of reasons, including receiving compensation for their efforts, no-cost medical exams, the chance to play a more active role in their own health care, gain access to new medical treatments before they are available to the wider public, and help others by contributing to the future of medical science.

There are plenty of misconceptions about what happens on a clinical research study. These are just that: myths. Your safety is our number one priority. Drug development is highly regulated with strict safety and ethical guidelines and we take those regulations very seriously. Your health is constantly monitored by specialized physicians with several years of experience.

Participating in our studies won’t cost you a dime. In fact, we compensate you for your efforts during the clinical trial. Our research staff also provides all study-related medication and care at no expense to you.

Our clinical studies are always voluntary. You are free to withdraw your consent at any time. Once you’ve already started the clinical study, our doctors may need you to come back for a visit, just to check that the drug is out of your system.

Scroll to Top